Reevaluation of indirect field stimulation technique to demonstrate oxime effectiveness in OP-poisoning in muscles in vitro

Toxicology

Volumn 233, Issue 1-3 SPEC. ISS., 2007, Pages 209-213

  Seeger, T ^a   Worek, F ^a   Szinicz, L ^a   Thiermann, H ^a  

^a BUNDESWEHR INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (Germany)

Author keywords

Diaphragm; Indirect field stimulation; Mouse; Obidoxim; Oximes; Paraoxon

Indexed keywords

ACETYLCHOLINESTERASE; ANTIDOTE; BIS(PYRIDINIUM OXIME) DERIVATIVE; NICOTINIC RECEPTOR BLOCKING AGENT; OBIDOXIME; ORGANOPHOSPHORUS COMPOUND; OXIME DERIVATIVE; PANCURONIUM; PARAOXON; SOMAN; TUBOCURARINE CHLORIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRIC FIELD; ELECTROSTIMULATION; FATALITY; IN VITRO STUDY; MALE; MOUSE; MUSCLE CONTRACTION; MUSCLE EXCITATION; MUSCLE FORCE; MUSCLE FUNCTION; NERVE STIMULATION; NEUROMUSCULAR SYNAPSE; NEUROTOXICITY; NONHUMAN; PHRENIC NERVE; PRIORITY JOURNAL; RESPIRATORY FAILURE;

ANIMALS; DIAPHRAGM; ELECTRIC STIMULATION; MALE; MICE; MICE, INBRED STRAINS; MUSCLE CONTRACTION; NEUROMUSCULAR BLOCKING AGENTS; OXIMES; PANCURONIUM; PARAOXON; TUBOCURARINE;

EID: 33947677245     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.12.017     Document Type: Article

References (18)

1. Baird W.L., and Reid A.M. The neuromuscular blocking properties of a new steroid compound, pancuronium bromide. A pilot study in man. Br. J. Anaesth. 39 (1967) 775-780
2. Bismuth C., Inns R.H., and Marrs T.C. Efficacy, toxicity and clinical use of oximes in anticholinesterase poisoning. In: Ballantyne B., and Marrs T.C. (Eds). Clinical and Experimental Toxicology of Organophosphates and Carbamates (1992), Butterworth and Heinemann, Oxford 555-577
3. Buckett W.R., Marjoribanks C.E., Marwick F.A., and Morton M.B. The pharmacology of pancuronium bromide (Org.NA97), a new potent steroidal neuromuscular blocking agent. Br. J. Pharmacol. Chem. 32 (1968) 671-682
4. Burd P.F., and Ferry C.B. A prolonged contraction at the end-plate region of the diaphragm of rats and mice after anticholinesterases in vitro. J. Physiol. 391 (1987) 429-440
5. Farrell L., Dempsey M.J., Waud B.E., and Waud D.R. Temperature and potency of d-tubocurarine and pancuronium in vitro. Anesth. Analg. 60 (1981) 18-20
6. Garland C.M., Foreman R.C., Chad J.E., Holden-Dye L., and Walker R.J. The actions of muscle relaxants at nicotinic acetylcholine receptor isoforms. Eur. J. Pharmacol. 357 (1998) 83-92
7. Holmstedt B. Pharmacology of organophosphorus cholinesterase inhibitors. Pharmacol. Rev. 11 (1959) 567-688
8. Kelly S.S., Ferry C.B., and Bamforth J.P. The effects of anticholinesterases on the latencies of action potentials in mouse skeletal muscles. Br. J. Pharmacol. 99 (1990) 721-726
9. Reddy V.K., Deshpande S.S., Cintra W.M., Scoble G.T., and Albuquerque E.X. Effectiveness of oximes 2-PAM and HI-6 in recovery of muscle function depressed by organophosphate agents in the rat hemidiaphragm: an in vitro study. Fundam. Appl. Toxicol. 17 (1991) 746-760
10. Rushton W.A. Excitable substances in the nerve-muscle complex. J. Physiol. 70 (1930) 317-337
11. Segal S.S., and Faulkner J.A. Temperature-dependent physiological stability of rat skeletal muscle in vitro. Am. J. Physiol. 248 (1985) C265-C270
12. Steinbach J.H., and Chen Q. Antagonist and partial agonist actions of d-tubocurarine at mammalian muscle acetylcholine receptors. J. Neurosci. 15 (1995) 230-240
13. Thiermann H., Eyer P., Worek F., and Szinicz L. Effects of oximes on muscle force and acetylcholinesterase activity in isolated mouse hemidiaphragms exposed to paraoxon. Toxicology 214 (2005) 190-197
14. Vizi E.S., Somogyi G.T., Nagashima H., Duncalf D., Chaudhry I.A., Kobayashi O., Goldiner P.L., and Foldes F.F. Tubocurarine and pancuronium inhibit evoked release of acetylcholine from the mouse hemidiaphragm preparation. Br. J. Anaesth. 59 (1987) 226-231
15. Wenningmann I., and Dilger J.P. The kinetics of inhibition of nicotinic acetylcholine receptors by (+)-tubocurarine and pancuronium. Mol. Pharmacol. 60 (2001) 790-796
16. Wessler I., Halank M., Rasbach J., and Kilbinger H. Presynaptic nicotine receptors mediating a positive feed-back on transmitter release from the rat phrenic nerve. Naunyn. Schmiedebergs Arch. Pharmacol. 34 (1986) 365-372
17. Wolthuis O.L., and Kepner L.A. Successful oxime therapy 1 h after soman intoxication in the rat. Eur. J. Pharmacol. 49 (1978) 415-425
18. Wolthuis O.L., Vanwersch R.A.P., and Van Der Wiel H.J. The efficacy of some bis-pyridinium oximes as antidotes to soman in isolated muscles of several species including man. Eur. J. Pharmacol. 70 (1981) 355-369